Proinflammatory cytokines in heart failure: double-edged swords
- PMID: 20405319
- DOI: 10.1007/s10741-010-9168-4
Proinflammatory cytokines in heart failure: double-edged swords
Abstract
Increased circulating and intracardiac levels of proinflammatory cytokines have been associated with chronic heart failure. Following an initial insult, the increased production of proinflammatory cytokines, including TNF-α, IL-6, IL-1, and IL-18, jeopardizes the surrounding tissue through propagation of the inflammatory response and direct effects on the cardiac myocyte structure and function. Cardiac myocyte hypertrophy, contractile dysfunction, cardiac myocyte apoptosis, and extracellular matrix remodeling contribute enormously to the development and progression of chronic heart failure. Despite the identification of efficacious pharmacological regimens and introduction of mechanical interventions, chronic heart failure remains among the leading causes of mortality worldwide. To introduce novel therapeutic strategies that modulate the inflammatory response in the context of the failing heart, it is of prime importance to determine the contributions of TNF-α, IL-6, IL-1, and IL-18 in mediating cardiac adaptive and maladaptive responses, as well as delineating their downstream intracellular signaling pathways and their potential therapeutic implications.
Similar articles
-
Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.Am J Cardiol. 2009 Feb 1;103(3):399-404. doi: 10.1016/j.amjcard.2008.09.096. Epub 2008 Nov 21. Am J Cardiol. 2009. PMID: 19166697
-
[Cytokines and remodeling of the heart in patients with congestive heart failure].Pol Arch Med Wewn. 2003 Jan;109(1):23-33. Pol Arch Med Wewn. 2003. PMID: 12879763 Polish.
-
Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?Ann Surg. 1997 May;225(5):530-41; discussion 541-3. doi: 10.1097/00000658-199705000-00010. Ann Surg. 1997. PMID: 9193181 Free PMC article.
-
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.Cardiovasc Drugs Ther. 2020 Dec;34(6):849-863. doi: 10.1007/s10557-020-07071-0. Epub 2020 Sep 9. Cardiovasc Drugs Ther. 2020. PMID: 32902739 Free PMC article. Review.
-
Cytokines and cardiomyocyte death.Ann Med. 1997 Aug;29(4):339-43. doi: 10.3109/07853899708999358. Ann Med. 1997. PMID: 9375993 Review.
Cited by
-
Cardioprotective effect of ghrelin in cardiopulmonary bypass involves a reduction in inflammatory response.PLoS One. 2013;8(1):e55021. doi: 10.1371/journal.pone.0055021. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23359315 Free PMC article.
-
Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.Heart Fail Rev. 2014 Nov;19(6):759-79. doi: 10.1007/s10741-014-9427-x. Heart Fail Rev. 2014. PMID: 24573960 Review.
-
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Heart Fail Rev. 2012 Mar;17(2):177-90. doi: 10.1007/s10741-011-9261-3. Heart Fail Rev. 2012. PMID: 21688186 Free PMC article. Review.
-
Acidic preconditioning of endothelial colony-forming cells (ECFC) promote vasculogenesis under proinflammatory and high glucose conditions in vitro and in vivo.Stem Cell Res Ther. 2018 May 2;9(1):120. doi: 10.1186/s13287-018-0872-7. Stem Cell Res Ther. 2018. PMID: 29720269 Free PMC article.
-
IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function.Circ Heart Fail. 2012 May 1;5(3):366-75. doi: 10.1161/CIRCHEARTFAILURE.111.963769. Epub 2012 Mar 27. Circ Heart Fail. 2012. PMID: 22454393 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous